Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
antiviral activity, type I IFN, Immunoregulation, multiple scleorsis (MS), SARS-CoV-2
Cinthia Farina, Martina Severa, Marco Salvetti, Eliana Marina Coccia